Commit To Purchase BioXcel Therapeutics At $1.50, Earn 19.6% Annualized Using Options
March 13, 2024 at 13:48 PM EDT
Investors eyeing a purchase of BioXcel Therapeutics Inc (BTAI) stock, but cautious about paying the going market price of $2.78/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2025 put at the $1.50 strike, which has a bid at the time of this writing of 25 cents..